⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for treatment naïve

Every month we try and update this database with for treatment naïve cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive ChemotherapyNCT03069352
Acute Myeloid L...
Placebo
Venetoclax
Cytarabine
18 Years - AbbVie
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT05785767
Advanced Non-Sm...
fianlimab
cemiplimab
Placebo
18 Years - Regeneron Pharmaceuticals
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT05785767
Advanced Non-Sm...
fianlimab
cemiplimab
Placebo
18 Years - Regeneron Pharmaceuticals
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone LymphomaNCT04212013
Marginal Zone L...
Ibrutinib
Rituximab
Placebo
18 Years - Memorial Sloan Kettering Cancer Center
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone LymphomaNCT04212013
Marginal Zone L...
Ibrutinib
Rituximab
Placebo
18 Years - Memorial Sloan Kettering Cancer Center
Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular LymphomaNCT03828448
Follicular Lymp...
Small Lymphocyt...
Ublituximab
Umbralisib
18 Years - TG Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: